The Cannabist Co. will sell its vertically integrated permit in Virginia to a Boston-based hedge fund rather than competing ...

Cannabis' sworn enemy revealed itself to be behind the voter initiative campaigns seeking to roll back $1.9 billion in annual sales.

The U.S. cannabis industry continued to pullback in the third quarter of 2025, according to licensing data from intelligence ...

Marijuana rescheduling isn't official yet. Here's what needs to happen for cannabis to be downgraded under federal law.

The Alabama medical marijuana market could finally open in the spring after regulators finally awarded dispensary permits.

Cannabis will be moved to Schedule 3 of the Controlled Substances Act under an executive order President Donald Trump signed Thursday.

President Donald Trump's order to reclassify cannabis as a Schedule 3 drug is a huge step forward - but operators must know its limits.

Cannabis and hemp THC companies stand to benefit if marijuana is reclassified to Schedule 3, but banking and investment needs more reform.

Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly issued ...

New Jersey legislators are moving forward with a bill that could reshape the state’s market for hemp-derived cannabinoids.

With President Donald Trump’s executive order to reschedule cannabis, businesses in the industry are rolling out their growth strategies.